Biotechgate Global Database ›
News in the Life Sciences Industry | |
| Results 1 - 3 out of 3 displayed. | |
GHIT Fund Announces New Investments: A Total of 630 Million Yen in Drugs for Malaria, Tuberculosis, Chagas Disease and Leishmaniasis, Vaccines for Malaria and Chagas Disease, and Diagnostics for Malaria |
TOKYO, Sept. 30, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 630 million yen (US$5.9 million*) to invest in eight partnerships to develop new lifesaving drugs, vaccines and diagnostics for malaria, tuberculosis, Chagas disease and leishmaniasis.... Read more ›› |
| By: PR Newswire Association LLC. - 30 Sep 2019 |
Ardigen Was Accepted Into the Prestigious TESLA Consortium Working to Improve Personalization of Immunotherapies |
KRAKÓW, Poland, Sept. 3, 2019 /PRNewswire/ -- We are proud to announce that Ardigen was accepted into the international Tumour neoantigEn SeLection Alliance (TESLA). The consortium was founded by the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI). TESLA is... Read more ›› |
| By: PR Newswire Association LLC. - 03 Sep 2019 |
| Related companies: Ardigen S.A. |
Qu Biologics publishes potentially paradigm-shifting results of their first randomized-placebo controlled trial for the treatment of Crohn’s disease |
| Read more ›› |
| By: Nasdaq / GlobenewsWire - 23 Jul 2019 |
Partners
Upcoming Life Sciences Events
- October 2019
- Rennes: NutrEvent
- San Francisco: BIO Investor Forum
- Melbourne: Biotech-Pharma Product and Company Valuation - introduction
